These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 9190954)

  • 1. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
    Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice.
    Avichezer D; Chan CC; Silver PB; Wiggert B; Caspi RR
    Exp Eye Res; 2000 Aug; 71(2):111-8. PubMed ID: 10930316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis.
    Agarwal RK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1999 Mar; 162(5):2648-54. PubMed ID: 10072507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response.
    Sun B; Rizzo LV; Sun SH; Chan CC; Wiggert B; Wilder RL; Caspi RR
    J Immunol; 1997 Jul; 159(2):1004-11. PubMed ID: 9218623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H; Rizzo LV; Silver PB; Caspi RR
    Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
    Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.
    Tarrant TK; Silver PB; Wahlsten JL; Rizzo LV; Chan CC; Wiggert B; Caspi RR
    J Exp Med; 1999 Jan; 189(2):219-30. PubMed ID: 9892605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice.
    Caspi RR; Chan CC; Grubbs BG; Silver PB; Wiggert B; Parsa CF; Bahmanyar S; Billiau A; Heremans H
    J Immunol; 1994 Jan; 152(2):890-9. PubMed ID: 8283058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis.
    Silver PB; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1280-4. PubMed ID: 10235566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.